Acciones de Estados Unidos: empresas por la I
Las cuentas oficiales de 106 empresas de Estados Unidos cuyo nombre empieza por la I: ingresos y beneficio del último ejercicio, tal como figuran en el informe anual (10-K) que cada una presenta ante la SEC, en dólares. Cada una enlaza su ficha, con el documento del que sale cada cifra.
| Empresa | Código | Ejercicio | Ingresos | Beneficio neto |
|---|---|---|---|---|
| i3 Verticals | NASDAQ: IIIV | 2025 | 213,2 M$ | 17,9 M$ |
| IA | NASDAQ: IA | 2025 | 84,3 M$ | 15,6 M$ |
| IBEX | NASDAQ: IBEX | 2026 | 644,1 M$ | 46,3 M$ |
| IBM | NYSE: IBM | 2025 | 67.535 M$ | 10.593 M$ |
| Ibotta | NYSE: IBTA | 2025 | 342,4 M$ | 3,6 M$ |
| Icahn Enterprises | NASDAQ: IEP | 2025 | 9.658 M$ | −299,0 M$ |
| ICF International | NASDAQ: ICFI | 2025 | 1.873 M$ | 91,6 M$ |
| Ichor | NASDAQ: ICHR | 2025 | 947,7 M$ | −52,8 M$ |
| ICU Medical | NASDAQ: ICUI | 2025 | 2.231 M$ | 0,7 M$ |
| Idacorp | NYSE: IDA | 2025 | 1.813 M$ | 323,5 M$ |
| Idaho Strategic Resources | NYSE: IDR | 2025 | 42,4 M$ | 16,7 M$ |
| IDEAYA Biosciences | NASDAQ: IDYA | 2025 | 218,7 M$ | −113,7 M$ |
| IDEX | NYSE: IEX | 2025 | 3.458 M$ | 483,2 M$ |
| IDEXX Laboratories | NASDAQ: IDXX | 2025 | 4.304 M$ | 1.059 M$ |
| IDT | NYSE: IDT | 2026 | 1.298 M$ | 86,6 M$ |
| IES | NASDAQ: IESC | 2025 | 3.371 M$ | 306,0 M$ |
| iHeartMedia | NASDAQ: IHRT | 2025 | 3.865 M$ | −472,9 M$ |
| Illinois Tool Works | NYSE: ITW | 2025 | 16.044 M$ | 3.066 M$ |
| Illumina | NASDAQ: ILMN | 2025 | 4.343 M$ | 850,0 M$ |
| IMAX | NYSE: IMAX | 2025 | 410,2 M$ | 34,9 M$ |
| Immersion | NASDAQ: IMMR | 2026 | 1.731 M$ | 4,5 M$ |
| Immix Biopharma | NASDAQ: IMMX | 2025 | — | −29,4 M$ |
| Immuneering | NASDAQ: IMRX | 2025 | — | −56,0 M$ |
| Immunitybio | NASDAQ: IBRX | 2025 | 113,3 M$ | −351,4 M$ |
| Immunocore | NASDAQ: IMCR | 2025 | 400,0 M$ | −35,5 M$ |
| Immunome | NASDAQ: IMNM | 2025 | 6,9 M$ | −212,4 M$ |
| Immunovant | NASDAQ: IMVT | 2026 | — | −505,6 M$ |
| Impinj | NASDAQ: PI | 2025 | 361,1 M$ | −10,8 M$ |
| Incyte | NASDAQ: INCY | 2025 | 5.141 M$ | 1.287 M$ |
| Independence Realty Trust | NYSE: IRT | 2025 | 657,7 M$ | 56,6 M$ |
| Independent Bank | NASDAQ: IBCP | 2025 | 225,7 M$ | 68,5 M$ |
| Independent Bank (INDB) | NASDAQ: INDB | 2025 | 857,5 M$ | 205,1 M$ |
| Indie Semiconductor | NASDAQ: INDI | 2025 | 217,4 M$ | −143,1 M$ |
| Indivior Pharmaceuticals | NASDAQ: INDV | 2025 | 1.239 M$ | 210,0 M$ |
| Industrial Logistics Properties Trust | NASDAQ: ILPT | 2025 | 448,8 M$ | −66,2 M$ |
| Information Services Group | NASDAQ: III | 2025 | 244,7 M$ | 9,3 M$ |
| InfuSystem | NYSE: INFU | 2025 | 143,4 M$ | 6,6 M$ |
| Ingersoll Rand | NYSE: IR | 2025 | 7.651 M$ | 581,4 M$ |
| Ingevity | NYSE: NGVT | 2025 | 1.168 M$ | −167,1 M$ |
| Ingles Markets | NASDAQ: IMKTA | 2025 | 5.334 M$ | 83,6 M$ |
| Ingram Micro | NYSE: INGM | 2025 | 52.556 M$ | 327,9 M$ |
| Ingredion | NYSE: INGR | 2025 | 7.219 M$ | 729,0 M$ |
| Inhibikase Therapeutics | NASDAQ: IKT | 2025 | — | −48,3 M$ |
| Inhibrx Biosciences | NASDAQ: INBX | 2025 | 1,3 M$ | −140,1 M$ |
| Innodata | NASDAQ: INOD | 2025 | 251,7 M$ | 32,2 M$ |
| Innospec | NASDAQ: IOSP | 2025 | 1.778 M$ | 116,6 M$ |
| InnovAge | NASDAQ: INNV | 2026 | 989,7 M$ | −2,5 M$ |
| Innovate | NYSE: VATE | 2025 | 1.246 M$ | −60,6 M$ |
| Innovative Industrial Properties | NYSE: IIPR | 2025 | 266,0 M$ | 118,2 M$ |
| Innovex International | NYSE: INVX | 2025 | 978,3 M$ | 83,3 M$ |
| Innoviva | NASDAQ: INVA | 2025 | 411,3 M$ | 271,2 M$ |
| Inogen | NASDAQ: INGN | 2025 | 348,7 M$ | −22,7 M$ |
| Inseego | NASDAQ: INSG | 2025 | 166,2 M$ | 0,8 M$ |
| Insight Enterprises | NASDAQ: NSIT | 2025 | 8.247 M$ | 157,3 M$ |
| Insmed | NASDAQ: INSM | 2025 | 606,4 M$ | −1.277 M$ |
| Insperity | NYSE: NSP | 2025 | 6.812 M$ | −7,0 M$ |
| Inspire Medical Systems | NYSE: INSP | 2025 | 912,0 M$ | 145,4 M$ |
| Inspired Entertainment | NASDAQ: INSE | 2025 | 304,1 M$ | −17,0 M$ |
| Installed Building Products | NYSE: IBP | 2025 | 2.971 M$ | 265,4 M$ |
| Insteel Industries | NYSE: IIIN | 2026 | 739,5 M$ | 29,5 M$ |
| Insulet | NASDAQ: PODD | 2025 | 2.708 M$ | 247,1 M$ |
| Intapp | NASDAQ: INTA | 2026 | 577,8 M$ | −41,3 M$ |
| Integer | NYSE: ITGR | 2025 | 1.854 M$ | 102,8 M$ |
| Integra Lifesciences | NASDAQ: IART | 2025 | 1.635 M$ | −516,5 M$ |
| Intel | NASDAQ: INTC | 2025 | 52.853 M$ | −267,0 M$ |
| Intellia Therapeutics | NASDAQ: NTLA | 2025 | 67,7 M$ | −412,7 M$ |
| Intellicheck | NASDAQ: IDN | 2025 | 22,7 M$ | 1,3 M$ |
| Interactive Brokers | NASDAQ: IBKR | 2025 | 6.205 M$ | 4.357 M$ |
| Intercontinental Exchange | NYSE: ICE | 2025 | 12.640 M$ | 3.315 M$ |
| Intercorp Financial Services | NYSE: IFS | 2025 | — | 1.932 M PEN |
| InterDigital | NASDAQ: IDCC | 2025 | 834,0 M$ | 406,6 M$ |
| Interface | NASDAQ: TILE | 2025 | 1.387 M$ | 116,1 M$ |
| International Bancshares | NYSE: IBOC | 2025 | 842,2 M$ | 412,3 M$ |
| International Flavors & Fragrances | NYSE: IFF | 2025 | 10.890 M$ | −359,0 M$ |
| International Money Express | NASDAQ: IMXI | 2025 | 607,8 M$ | 32,7 M$ |
| International Paper | NYSE: IP | 2025 | 23.634 M$ | −3.516 M$ |
| International Seaways | NYSE: INSW | 2025 | 843,3 M$ | 309,3 M$ |
| Interparfums | NASDAQ: IPAR | 2025 | 1.489 M$ | 168,4 M$ |
| Intest | NYSE: INTT | 2025 | 113,8 M$ | −2,5 M$ |
| Intrepid Potash | NYSE: IPI | 2025 | 298,3 M$ | 11,2 M$ |
| Intuit | NASDAQ: INTU | 2026 | 21.448 M$ | 4.566 M$ |
| Intuitive Machines | NASDAQ: LUNR | 2025 | 210,1 M$ | −83,3 M$ |
| Intuitive Surgical | NASDAQ: ISRG | 2025 | 10.065 M$ | 2.856 M$ |
| Inventrust Properties | NYSE: IVT | 2025 | 299,2 M$ | 111,4 M$ |
| Invesco | NYSE: IVZ | 2025 | 6.377 M$ | −174,8 M$ |
| Invesco Mortgage Capital | NYSE: IVR | 2025 | 295,3 M$ | 101,3 M$ |
| Investar | NASDAQ: ISTR | 2025 | 93,6 M$ | 22,9 M$ |
| Investors Title | NASDAQ: ITIC | 2025 | 272,8 M$ | 35,2 M$ |
| Invitation Homes | NYSE: INVH | 2025 | 2.729 M$ | 587,9 M$ |
| Invivyd | NASDAQ: IVVD | 2025 | 53,4 M$ | −52,5 M$ |
| Ionis Pharmaceuticals | NASDAQ: IONS | 2025 | 943,7 M$ | −381,4 M$ |
| IonQ | NYSE: IONQ | 2025 | 130,0 M$ | −510,4 M$ |
| Iovance Biotherapeutics | NASDAQ: IOVA | 2025 | 263,5 M$ | −391,0 M$ |
| IPG Photonics | NASDAQ: IPGP | 2025 | 1.004 M$ | 31,1 M$ |
| IQVIA | NYSE: IQV | 2025 | 16.310 M$ | 1.360 M$ |
| Iradimed | NASDAQ: IRMD | 2025 | 83,8 M$ | 22,5 M$ |
| IREN | NASDAQ: IREN | 2026 | 707,0 M$ | −702,6 M$ |
| iRhythm | NASDAQ: IRTC | 2025 | 747,1 M$ | −44,6 M$ |
| Iridium Communications | NASDAQ: IRDM | 2025 | 871,7 M$ | 114,4 M$ |
| Iron Mountain | NYSE: IRM | 2025 | 6.902 M$ | 152,3 M$ |
| Ironwood Pharmaceuticals | NASDAQ: IRWD | 2025 | 296,2 M$ | 24,0 M$ |
| IRSA | NYSE: IRS | 2026 | — | 393.510 M ARS |
| Isabella Bank | NASDAQ: ISBA | 2025 | 78,5 M$ | 18,9 M$ |
| Itaú Unibanco | NYSE: ITUB | 2025 | 167.780 M BRL | 44.857 M BRL |
| Itron | NASDAQ: ITRI | 2025 | 2.367 M$ | 301,1 M$ |
| ITT | NYSE: ITT | 2025 | 3.939 M$ | 488,0 M$ |
Información elaborada con las cuentas que cada empresa presenta ante el regulador, con fines informativos. No es asesoramiento financiero ni una recomendación de compra o venta.